Dr. Pokorney is an electrophysiologist and Assistant Professor of Medicine at Duke University. His areas of expertise include treatment options related to stroke prevention in atrial fibrillation, bleeding management in atrial fibrillation, atrial fibrillation prevention and rhythm management, contact force-sensing catheters, the use of antiarrhythmic medications, risk of sudden death and use of implantable cardioverter-defibrillators after acute cardiovascular events, and lead management for patients with cardiac implantable electronic devices. He received his MD and his MBA in Health Industry Management from Northwestern University. His post-graduate training included a Clinical Research Fellowship at the Duke Clinical Research Institute, as well as a Cardiovascular Disease Fellowship and an Electrophysiology Fellowship at the Duke University Medical Center. Dr. Pokorney has contributed book chapters on pharmacological management of atrial fibrillation in the outpatient setting and on managing recurrent implanted cardioverter defibrillator (ICD) therapies. He has also presented on the Food and Drug Administration’s restriction of edoxaban use in atrial fibrillation patients with normal renal function and on the low rates of ICD use among Medicare patients with low ejection fraction after acute myocardial infarction. Dr. Pokorney’s research has been published in peer-reviewed journals such as the JAMA, Lancet, Circulation, Journal of the American College of Cardiology, Heart Rhythm, JACC Electrophysiology, Circulation Arrhythmia and Electrophysiology, American Heart Journal, American Journal of Cardiology, and Journal of the American Heart Association.